A E Maluish
- Immunology top 5%
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 4
- Immune Response and Inflammation 3
- T-cell and Retrovirus Studies 2
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions 3
- Cancer Immunotherapy and Biomarkers 2
-
- Erythropoietin and Anemia Treatment 1
-
- Chemical Synthesis and Analysis 1
- Co-authors
- R B HerbermanD M StrongTetsuhisa GotoR. K. OldhamStephen A. SherwinW.J. HallidayWilliam H. IsbisterRonald G. Steis
- Cited by
- ImmunologyOncologyGenetics
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
A E Maluish
16 papers receiving 805 citations
Peers
Comparison fields: 5 of 80
- Immunology 570
- Oncology 248
- Genetics 56
- Hematology 54
- Pathology and Forensic Medicine 76
Countries citing papers authored by A E Maluish
This map shows the geographic impact of A E Maluish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A E Maluish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A E Maluish more than expected).
Fields of papers citing papers by A E Maluish
This network shows the impact of papers produced by A E Maluish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A E Maluish. The network helps show where A E Maluish may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A E Maluish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer. | 1990 | 49 |
| 2 | 1988 | 103 | |
| 3 | 1988 | 49 | |
| 4 | Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donors. | 1987 | 19 |
| 5 | Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations. | 1986 | 13 |
| 6 | 1986 | 33 | |
| 7 | 1985 | 81 | |
| 8 | 1985 | 74 | |
| 9 | A trial of autologous plasma perfusion over protein A in patients with breast cancer. | 1984 | 10 |
| 10 | A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer. | 1984 | 19 |
| 11 | 1983 | 147 | |
| 12 | 1983 | 72 | |
| 13 | 1982 | 112 | |
| 14 | 1975 | 1 | |
| 15 | 1974 | 18 | |
| 16 | 1974 | 75 |
About A E Maluish
A E Maluish is a scholar working on Immunology, Oncology and Complementary and alternative medicine, having authored 16 papers that have together received 875 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Immune Response and Inflammation (3 papers), T-cell and Retrovirus Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Chemical Synthesis and Analysis (1 paper) and Erythropoietin and Anemia Treatment (1 paper). The work is most often cited by research in Immunology (570 citations), Oncology (248 citations) and Genetics (56 citations). A E Maluish has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include R B Herberman, D M Strong, Tetsuhisa Goto, R. K. Oldham, Stephen A. Sherwin, W.J. Halliday, William H. Isbister, Ronald G. Steis, C. Schoenberger and Seymour Fein. Their work appears in journals such as The Journal of Immunology, JAMA, Journal of Clinical Oncology, British Journal of Cancer and The Medical Journal of Australia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.